Lansoprazol Ab

Lansoprazole, the active ingredient in Lansoprazol Ab, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid secretion and is employed in the management of gastro‑oesophageal reflux disease, peptic ulcer disease, erosive oesophagitis and as part of Helicobacter pylori eradication regimens.

GNH USA supplies Lansoprazol Ab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole is indicated for several acid‑related conditions, acting on the gastric proton pump to lower acid output.

- Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and esophageal irritation. - Peptic ulcer disease: promotes ulcer healing by reducing gastric acidity. - Helicobacter pylori eradication: used in combination therapy to increase eradication rates. - Erosive oesophagitis: heals mucosal damage caused by acid reflux.

Adverse reactions may occur with lansoprazole use.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: watery stools, usually transient. - Nausea: occasional upset stomach. - Abdominal pain: cramping or discomfort. - Flatulence: increased gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent diarrhea, abdominal pain. - Low magnesium levels: muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: abnormal liver function tests. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

Before prescribing lansoprazole, consider the following precautions.

- Assess renal function: adjust use in severe impairment. - Evaluate hepatic status: use with caution in liver disease. - Review long‑term therapy: monitor for bone density loss. - Monitor electrolytes: especially magnesium during prolonged treatment. - Consider infection risk: prolonged acid suppression may increase gastrointestinal infections. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and light.

Lansoprazole may interact with several medicines; awareness of interaction severity guides management.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect; consider alternative therapy. - Atazanavir: decreased absorption; avoid co‑administration. - Methotrexate (high dose): increased toxicity risk.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR; monitor coagulation. - Digoxin: altered serum levels; check concentrations. - Diazepam: increased plasma concentration; observe for sedation. - Ketoconazole/Itraconazole: reduced antifungal efficacy; consider dosage adjustment.